Scientific Team
Head Consultant of QR Laboratory Scientific Team
Dr Vassilis G Gorgoulis
MD, PhD, Professor-Director
Main research interests include: Mechanisms leading to genomic instability; The role of the DNA damage response network as an anti-tumor barrier (eliciting apoptosis or senescence) and mechanisms leading to escape from these barriers; Development of new compounds and methods to detect senescent cells with precision; The role of the replication licensing machinery in cancer progression; Development of machine learning algorithms to predict biological/drug responses.
Founder / Representative for the US
Nicholas Kotopoulos MD
Founder / Representative for the US
Board Certified Physician practicing in the states of New York and New Jersey for over 45 years. Medical Director and owner of three separate state licensed ambulatory surgery centers and one state licensed pathology laboratory in the state of New Jersey.
QR Laboratory representative for the US
United States based location:
QR Laboratories
44 Engle Street
Englewood, New Jersey
Orestis Kotopoulos, Esq.
General Counsel/Operative Manager
QR Scientific Officer, Head of mAb Production
Demetris Vassilakos
BSc, Msc, PhD, Scientific Officer, Head of Production
QR scientific team
The team comprises of three senior scientists and one research scientist with extensive experience in monoclonal antibody generation, analysis and characterization such as immunoassays, immunohistochemistry, immunocytochemistry, immunofluorescence and flow cytometry.
QR’s scientific team exhibits a long track record of experience in the development, generation, purification and characterization of monoclonal antibodies.
Our innovative approach to hybridoma technology has enabled the efficient production of highly specific antibodies.